{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T16:01:22Z","timestamp":1795104082207,"version":"4.10.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T00:00:00Z","timestamp":1528070400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12887-018-1156-1","type":"journal-article","created":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T12:34:43Z","timestamp":1528115683000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Elevated IgM levels as a marker for a unique phenotype in patients with Ataxia telangiectasia"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3120-7736","authenticated-orcid":false,"given":"Alexander","family":"Krauthammer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avishay","family":"Lahad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lior","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ifat","family":"Sarouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Batia","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raz","family":"Somech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michalle","family":"Soudack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itai M.","family":"Pessach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,4]]},"reference":[{"key":"1156_CR1","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1146\/annurev-pathol-011811-132509","volume":"7","author":"PJ McKinnon","year":"2012","unstructured":"McKinnon PJ. ATM and the molecular pathogenesis of ataxia telangiectasia. Annu Rev Pathol. 2012;7:303\u201321. \n                    https:\/\/doi.org\/10.1146\/annurev-pathol-011811-132509\n                    \n                  .","journal-title":"Annu Rev Pathol"},{"issue":"4","key":"1156_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrm3546","volume":"14","author":"Y Shiloh","year":"2013","unstructured":"Shiloh Y, Ziv Y. The ATM protein kinase: regulating the cellular response to genotoxic stress, and more. Nat Rev Mol Cell Biol. 2013;14(4):197\u2013210. \n                    https:\/\/doi.org\/10.1038\/nrm3546\n                    \n                  .","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"1156_CR3","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jpeds.2003.12.046","volume":"144","author":"A Nowak-Wegrzyn","year":"2004","unstructured":"Nowak-Wegrzyn A, Crawford TO, Winkelstein JA, Carson KA, Lederman HM. Immunodeficiency and infections in Ataxia telangiectasia. J Pediatr. 2004;144(4):505\u201311. \n                    https:\/\/doi.org\/10.1016\/j.jpeds.2003.12.046\n                    \n                  .","journal-title":"J Pediatr"},{"issue":"4","key":"1156_CR4","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S1071-9091(98)80007-7","volume":"5","author":"TO Crawford","year":"1998","unstructured":"Crawford TO. Ataxia telangiectasia. Semin Pediatr Neurol. 1998;5(4):287\u201394. \n                    https:\/\/doi.org\/10.1016\/S1071-9091(98)80007-7\n                    \n                  .","journal-title":"Semin Pediatr Neurol"},{"issue":"2","key":"1156_CR5","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/cei.12262","volume":"176","author":"C Chopra","year":"2014","unstructured":"Chopra C, Davies G, Taylor M, Anderson M, Bainbridge S, Tighe P, McDermott EM. Immune deficiency in Ataxia-telangiectasia: a longitudinal study of 44 patients. Clin Exp Immunol. 2014;176(2):275\u201382. \n                    https:\/\/doi.org\/10.1111\/cei.12262\n                    \n                  .","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"1156_CR6","first-page":"320","volume":"59","author":"CM McConville","year":"1996","unstructured":"McConville CM, Stankovic T, Byrd PJ, McGuire GM, Yao QY, Lennox GG, Taylor MR. Mutations associated with variant phenotypes in ataxia-telangiectasia. Am J Hum Genet. 1996;59(2):320\u201330.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"1156_CR7","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/j.1365-2249.2008.03684.x","volume":"153","author":"ER Staples","year":"2008","unstructured":"Staples ER, McDermott EM, Reiman A, Byrd PJ, Ritchie S, Taylor AM, Davies EG. Immunodeficiency in ataxia telangiectasia is correlated strongly with the presence of two null mutations in the ataxia telangiectasia mutated gene. Clin Exp Immunol. 2008;153(2):214\u201320. \n                    https:\/\/doi.org\/10.1111\/j.1365-2249.2008.03684.x\n                    \n                  .","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"1156_CR8","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s10875-014-0044-1","volume":"34","author":"M Kraus","year":"2014","unstructured":"Kraus M, Lev A, Simon AJ, Levran I, Nissenkorn A, Levi YB, Berkun Y, Efrati O, Amariglio N, Rechavi G, Somech R. Disturbed B and T cell homeostasis and neogenesis in patients with ataxia telangiectasia. J Clin Immunol. 2014;34(5):561\u201372. \n                    https:\/\/doi.org\/10.1007\/s10875-014-0044-1\n                    \n                  .","journal-title":"J Clin Immunol"},{"issue":"15","key":"1156_CR9","doi-asserted-by":"publisher","first-page":"6323","DOI":"10.1073\/pnas.0611222104","volume":"104","author":"MS Vacchio","year":"2007","unstructured":"Vacchio MS, Olaru A, Livak F, Hodes RJ. ATM deficiency impairs thymocyte maturation because of defective resolution of T cell receptor alpha locus coding end breaks. Proc Natl Acad Sci U S A. 2007;104(15):6323\u20138. \n                    https:\/\/doi.org\/10.1073\/pnas.0611222104\n                    \n                  .","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1156_CR10","first-page":"205","volume":"33","author":"F Ersoy","year":"1991","unstructured":"Ersoy F, Berkel AI, Sanal O, Oktay H. Twenty-year follow-up of 160 patients with ataxia-telangiectasia. Turk J Pediatr. 1991;33(4):205\u201315.","journal-title":"Turk J Pediatr"},{"issue":"4","key":"1156_CR11","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/ppul.22817","volume":"49","author":"SA Schroeder","year":"2014","unstructured":"Schroeder SA, Zielen S. Infections of the respiratory system in patients with ataxia-telangiectasia. Pediatr Pulmonol. 2014;49(4):389\u201399. \n                    https:\/\/doi.org\/10.1002\/ppul.22817\n                    \n                  .","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"1156_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13023-016-0543-7","volume":"11","author":"C Rothblum-Oviatt","year":"2016","unstructured":"Rothblum-Oviatt C, Wright J, Lefton-Greif MA, McGrath-Morrow SA, Crawford TO, Lederman HM. Ataxia telangiectasia: a review. Orphanet J Rare Dis. 2016;11(1):159. \n                    https:\/\/doi.org\/10.1186\/s13023-016-0543-7\n                    \n                  .","journal-title":"Orphanet J Rare Dis"},{"issue":"20","key":"1156_CR13","doi-asserted-by":"publisher","first-page":"4036","DOI":"10.1182\/blood-2012-09-456897","volume":"121","author":"M Ambrose","year":"2013","unstructured":"Ambrose M, Gatti RA. Pathogenesis of ataxia-telangiectasia: the next generation of ATM functions. Blood. 2013;121(20):4036\u201345. \n                    https:\/\/doi.org\/10.1182\/blood-2012-09-456897\n                    \n                  .","journal-title":"Blood"},{"issue":"4","key":"1156_CR14","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/MPG.0000000000001036","volume":"62","author":"B Weiss","year":"2016","unstructured":"Weiss B, Krauthammer A, Soudack M, Lahad A, Sarouk I, Somech R, Heimer G, Ben-Zeev B, Nissenkorn A. Liver Disease in Pediatric Patients with Ataxia Telangiectasia: A Novel Report. J Pediatr Gastroenterol Nutr. 2016;62(4):550\u20135. \n                    https:\/\/doi.org\/10.1097\/MPG.0000000000001036\n                    \n                  .","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"6","key":"1156_CR15","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1136\/adc.2008.149351","volume":"94","author":"JG Noordzij","year":"2009","unstructured":"Noordzij JG, Wulffraat NM, Haraldsson A, Meyts I, Van't Veer LJ, Hogervorst FB, Warris A, Weemaes CM. Ataxia-telangiectasia patients presenting with hyper-IgM syndrome. Arch Dis Child. 2009;94(6):448\u20139. \n                    https:\/\/doi.org\/10.1136\/adc.2008.149351\n                    \n                  .","journal-title":"Arch Dis Child"},{"issue":"5","key":"1156_CR16","first-page":"442","volume":"20","author":"A Aghamohammadi","year":"2010","unstructured":"Aghamohammadi A, Imai K, Moazzami K, Abolhassani H, Tabatabaeiyan M, Parvaneh N, Nasiri Kalmarzi R, Nakagawa N, Oshima K, Ohara O, Nonoyama S, Rezaei N. Ataxia-telangiectasia in a patient presenting with hyper-immunoglobulin M syndrome. J Investig Allergol Clin Immunol. 2010;20(5):442\u20135.","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"3","key":"1156_CR17","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s12098-015-1852-x","volume":"83","author":"A Rawat","year":"2016","unstructured":"Rawat A, Imai K, Suri D, Gupta A, Bhisikar S, Saikia B, Minz RW, Sehgal S, Singh S. Ataxia telangiectasia masquerading as hyper IgM syndrome. Indian J Pediatr. 2016;83(3):270\u20131. \n                    https:\/\/doi.org\/10.1007\/s12098-015-1852-x\n                    \n                  .","journal-title":"Indian J Pediatr"},{"issue":"6","key":"1156_CR18","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1067\/mpd.2001.113356","volume":"138","author":"N Tangsinmankong","year":"2001","unstructured":"Tangsinmankong N, Wayne AS, Howenstine MS, Washington KR, Langston C, Gatti RA, Good RA, Nelson RP Jr. Lymphocytic interstitial pneumonitis, elevated IgM concentration, and hepatosplenomegaly in ataxia-telangiectasia. J Pediatr. 2001;138(6):939\u201341. \n                    https:\/\/doi.org\/10.1067\/mpd.2001.113356\n                    \n                  .","journal-title":"J Pediatr"},{"issue":"3","key":"1156_CR19","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1177\/039463201402700312","volume":"27","author":"E Azarsiz","year":"2014","unstructured":"Azarsiz E, Karaca NE, Gunaydin NC, Gulez N, Ozturk C, Aksu G, Genel F, Kutukculer N. Do elevated serum IgM levels have to be included in probable diagnosis criteria of patients with ataxia-telangiectasia? Int J Immunopathol Pharmacol. 2014;27(3):421\u20137. \n                    https:\/\/doi.org\/10.1177\/039463201402700312\n                    \n                  .","journal-title":"Int J Immunopathol Pharmacol"},{"key":"1156_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.clim.2017.01.009","volume":"178","author":"NJH van Os","year":"2017","unstructured":"van Os NJH, Jansen AFM, et al. Ataxia-telangiectasia: immunodeficiency and survival. Clin Immunol. 2017;178:45\u201355. \n                    https:\/\/doi.org\/10.1016\/j.clim.2017.01.009\n                    \n                  .","journal-title":"Clin Immunol"},{"key":"1156_CR21","doi-asserted-by":"crossref","unstructured":"Winkelstein JA, Marino MC, Ochs H, Fuleihan R, Scholl PR, Geha R, Stiehm ER, Conley ME. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine (Baltimore). 2003;82(6):373\u201384. \n                    https:\/\/doi.org\/10.1097\/01.md.0000100046.06009.b0\n                    \n                  .","DOI":"10.1097\/01.md.0000100046.06009.b0"},{"key":"1156_CR22","doi-asserted-by":"crossref","unstructured":"de la Morena MT. Clinical Phenotypes of Hyper-IgM Syndromes. J Allergy Clin Immunol Pract. 2016;4(6):1023\u201336. \n                    https:\/\/doi.og\/10.1016\/j.jaip.2016.09.013\n                    \n                  .","DOI":"10.1016\/j.jaip.2016.09.013"},{"issue":"18","key":"1156_CR23","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1056\/NEJM196910302811818","volume":"281","author":"AJ Ammann","year":"1969","unstructured":"Ammann AJ. Respiratory complications of ataxia-telangiectasia. N Engl J Med. 1969;281(18):1019.","journal-title":"N Engl J Med"},{"issue":"3","key":"1156_CR24","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.jaci.2012.10.040","volume":"131","author":"A Lev","year":"2013","unstructured":"Lev A, Simon AJ, Broides A, Levi J, Garty BZ, Rosenthal E, et al. Thymic function in MHC class II-deficient patients. J Allergy Clin Immunol. 2013;131(3):831\u20139. \n                    https:\/\/doi.org\/10.1016\/j.jaci.2012.10.040\n                    \n                  .","journal-title":"J Allergy Clin Immunol"},{"key":"1156_CR25","doi-asserted-by":"publisher","unstructured":"Lev A, Simon AJ, Bareket M, Bielorai B, Hutt D, Amariglio N, et al. The kinetics of early T and B cell immune recovery after bone marrow transplantation in RAG-2-deficient SCID patients. PLoS One. 2012;7(1) \n                    https:\/\/doi.org\/10.1371\/journal.pone.0030494\n                    \n                  .","DOI":"10.1371\/journal.pone.0030494"},{"issue":"2","key":"1156_CR26","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1200\/JCO.2014.56.5101","volume":"33","author":"F Suarez","year":"2015","unstructured":"Suarez F, et al. Incidence, presentation, and prognosis of malignancies in ataxia-telangiectasia: a report from the French national registry of primary immune deficiencies. J Clin Oncol. 2015;33(2):202\u20138. \n                    https:\/\/doi.org\/10.1200\/JCO.2014.56.5101\n                    \n                  .","journal-title":"J Clin Oncol"},{"key":"1156_CR27","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/00005792-197207000-00002","volume":"51","author":"DE McFarlin","year":"1972","unstructured":"McFarlin DE, Strober W, Waldmann TA. Ataxia Telangiectasia. Medicine (Baltimore). 1972;51:281\u2013314.","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"1156_CR28","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1080\/1744666X.2017.1292131","volume":"13","author":"S Ghiasy","year":"2017","unstructured":"Ghiasy S, Parvaneh L, Azizi G, Sadri G, Zaki Dizaji M, Abolhassani H, Aghamohammadi A. The clinical significance of complete class switching defect in Ataxia telangiectasia patients. Expert Rev Clin Immunol. 2017;13(5):499\u2013505. \n                    https:\/\/doi.org\/10.1080\/1744666X.2017.1292131\n                    \n                  .","journal-title":"Expert Rev Clin Immunol"},{"issue":"5","key":"1156_CR29","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s10875-016-0291-4","volume":"36","author":"EA Leven","year":"2016","unstructured":"Leven EA, et al. Hyper IgM syndrome: a report from the USIDNET registry. J Clin Immunol. 2016;36(5):490\u2013501. \n                    https:\/\/doi.org\/10.1007\/s10875-016-0291-4\n                    \n                  .","journal-title":"J Clin Immunol"},{"key":"1156_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-017-0689-y","volume":"12","author":"TL Paulino","year":"2017","unstructured":"Paulino TL, Rafael MN, Hix S, Shigueoka DC, Ajzen SA, Kochi C, Suano-Souza FI, da Silva R, Costa-Carvalho BT, Sarni ROS. Is age a risk factor for liver disease and metabolic alterations in ataxia telangiectasia patients? Orphanet J Rare Dis. 2017;12:1\u20137. \n                    https:\/\/doi.org\/10.1186\/s13023-017-0689-y\n                    \n                  .","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"1156_CR31","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/bjc.2011.266","volume":"105","author":"A Reiman","year":"2011","unstructured":"Reiman A, et al. Lymphoid tumors and breast cancer in ataxia telangiectasia; substantial protective effect of residual ATM kinase activity against childhood tumours. Br J Cancer. 2011;105(4):586\u201391. \n                    https:\/\/doi.org\/10.1038\/bjc.2011.266\n                    \n                  .","journal-title":"Br J Cancer"},{"issue":"1","key":"1156_CR32","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1080\/15321819.2014.891525","volume":"36","author":"P Mohammadinejad","year":"2015","unstructured":"Mohammadinejad P, Abolhassani H, Aghamohammadi A, Pourhamdi S, Ghosh S, Sadeghi B, Nasiri Kalmarzi R, Durandy A, Borkhardt A. Class switch recombination process in ataxia telangiectasia patients with elevated serum levels of IgM. J Immunoassay Immunochem. 2015;36(1):16\u201326. \n                    https:\/\/doi.org\/10.1080\/15321819.2014.891525\n                    \n                  .","journal-title":"J Immunoassay Immunochem"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-018-1156-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12887-018-1156-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-018-1156-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T19:07:02Z","timestamp":1559588822000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-018-1156-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,4]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1156"],"URL":"https:\/\/doi.org\/10.1186\/s12887-018-1156-1","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,4]]},"assertion":[{"value":"7 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The above study was reviewed and approved by the Sheba Medical Center Institutional review board (SMC-IRB), (reference 2867\u201315-SMC). The data retrieved from all patient charts was coded and de identified prior to analysis. Since this study is a retrospective chart review study the need for written consent was formally waved by the SMC-IRB.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"185"}}